Cargando…

Plasmid-free CRISPR/Cas9 genome editing in Plasmodium falciparum confirms mutations conferring resistance to the dihydroisoquinolone clinical candidate SJ733

Genetic manipulation of the deadly malaria parasite Plasmodium falciparum remains challenging, but the rise of CRISPR/Cas9-based genome editing tools is increasing the feasibility of altering this parasite’s genome in order to study its biology. Of particular interest is the investigation of drug ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crawford, Emily D., Quan, Jenai, Horst, Jeremy A., Ebert, Daniel, Wu, Wesley, DeRisi, Joseph L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439709/ https://www.ncbi.nlm.nih.gov/pubmed/28542423 http://dx.doi.org/10.1371/journal.pone.0178163

Ejemplares similares

Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development
por: Gaur, Aditya H., et al.
Publicado: (2022)

Similarly efficacious anti-malarial drugs SJ733 and pyronaridine differ in their ability to remove circulating parasites in mice
por: SheelaNair, Arya, et al.
Publicado: (2022)

Efficient CRISPR/Cas9-mediated genome editing in P. falciparum
por: Wagner, Jeffrey C., et al.
Publicado: (2014)

Efficient CRISPR/Cas9 Plasmids for Rapid and Versatile Genome Editing in Drosophila
por: Gokcezade, Joseph, et al.
Publicado: (2014)

Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species
por: Lombardi, Lisa, et al.
Publicado: (2019)

CRISPR/Cas9 genome editing system confirms centriolin’s role in cytokinesis
por: Seronick, Eric, et al.
Publicado: (2022)

Optimization of CRISPR/Cas System for Improving Genome Editing Efficiency in Plasmodium falciparum
por: Zhao, Yuemeng, et al.
Publicado: (2021)

Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
por: Chen, Yizhe, et al.
Publicado: (2021)

CRISPR-Cas-Guided Mutagenesis of Chromosome and Virulence Plasmid in Shigella flexneri by Cytosine Base Editing
por: Sharma, Atin, et al.
Publicado: (2022)

A redesigned CRISPR/Cas9 system for marker-free genome editing in Plasmodium falciparum
por: Lu, Junnan, et al.
Publicado: (2016)

Robust genome editing in adult vascular endothelium by nanoparticle delivery of CRISPR-Cas9 plasmid DNA
por: Zhang, Xianming, et al.
Publicado: (2022)

Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing
por: Xiu, Kemao, et al.
Publicado: (2022)

The Use of CRISPR/Cas9 Gene Editing to Confirm Congenic Contaminations in Host-Pathogen Interaction Studies
por: Ferrand, Jonathan, et al.
Publicado: (2018)

In vivo Editing of the Human Mutant Rhodopsin Gene by Electroporation of Plasmid-based CRISPR/Cas9 in the Mouse Retina
por: Latella, Maria Carmela, et al.
Publicado: (2016)

Correction for Lombardi et al., “Plasmid-Based CRISPR-Cas9 Gene Editing in Multiple Candida Species”
por: Lombardi, Lisa, et al.
Publicado: (2020)

Establishment of an Integrated CRISPR/Cas9 Plasmid System for Simple and Efficient Genome Editing in Medaka In Vitro and In Vivo
por: Zhang, Zeming, et al.
Publicado: (2023)

Erratum to: A redesigned CRISPR/Cas9 system for marker-free genome editing in Plasmodium falciparum
por: Lu, Junnan, et al.
Publicado: (2016)

Combined IL-12 Plasmid and Recombinant SjGST Enhance the Protective and Anti-pathology Effect of SjGST DNA Vaccine Against Schistosoma japonicum
por: Cheng, Po-Ching, et al.
Publicado: (2016)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

High-efficiency nonviral CRISPR/Cas9-mediated gene editing of human T cells using plasmid donor DNA
por: Oh, Soyoung A., et al.
Publicado: (2022)

A selectable, plasmid-based system to generate CRISPR/Cas9 gene edited and knock-in mosquito cell lines
por: Rozen-Gagnon, Kathryn, et al.
Publicado: (2021)

An optimized electroporation approach for efficient CRISPR/Cas9 genome editing in murine zygotes
por: Tröder, Simon E., et al.
Publicado: (2018)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Genome Editing in Bacteria: CRISPR-Cas and Beyond
por: Arroyo-Olarte, Ruben D., et al.
Publicado: (2021)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis
por: Elmore, Joshua R., et al.
Publicado: (2013)

CRISPR-Cas System in Antibiotic Resistance Plasmids in Klebsiella pneumoniae
por: Kamruzzaman, Muhammad, et al.
Publicado: (2020)

A highly efficient in vivo plasmid editing tool based on CRISPR-Cas12a and phage λ Red recombineering
por: Geng, Yiman, et al.
Publicado: (2019)

Development and application of a rapid all-in-one plasmid CRISPR-Cas9 system for iterative genome editing in Bacillus subtilis
por: Zou, Yu, et al.
Publicado: (2022)

Development of an in vivo cleavable donor plasmid for targeted transgene integration by CRISPR-Cas9 and CRISPR-Cas12a
por: Ishibashi, Riki, et al.
Publicado: (2022)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
por: Shui, Bing, et al.
Publicado: (2016)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

Multiplex genome editing of microorganisms using CRISPR-Cas
por: Adiego-Pérez, Belén, et al.
Publicado: (2019)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

Applications of the CRISPR/Cas system beyond gene editing
por: Anton, Tobias, et al.
Publicado: (2018)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q1d65lor3vjg7ecpl0ju6saqc5